Stay Informed

Coherex Medical announces CE mark for the WaveCrest LAA Occlusion System

Published under Press Releases on

SALT LAKE CITY – September 3, 2013 – Coherex Medical, Inc. announced it has received CE Mark approval for its Coherex WaveCrest™ LAA Occlusion System. Atrial fibrillation (AF) is the most common cardiac arrhythmia in today’s aging population, effecting nearly 6 million individuals in the US alone. AF causes the upper chambers of the heart to beat irregularly, slowing the Continue Reading →

Coherex Medical Announces Exclusive Distribution Agreement with Biosense Webster

Published under Press Releases on

Coherex Medical, Inc. announced today that it has entered into an exclusive distribution agreement with Biosense Webster Inc. for the Coherex WaveCrest® LAA Occlusion System. Under terms of the agreement, Coherex will provide exclusive worldwide distribution rights, excluding the U.S., to Biosense Webster for the CE-marked Coherex WaveCrest Device. Biosense Webster, along with its affiliated company, Cordis Corporation, will promote, Continue Reading →

Coherex Medical Expands Portfolio with New Medical Device; New Heart Implant Treats Patients at Risk for Stroke

Published under Press Releases on

COHEREX MEDICAL EXPANDS PORTFOLIO WITH NEW MEDICAL DEVICE; NEW HEART IMPLANT TREATS PATIENTS AT RISK FOR STROKE * Coherex launches CE Mark study for its Coherex WaveCrest LAA Occluder System at Auckland City Hospital in New Zealand * World-leading cardiologist, Peter Ruygrok, M.D., performs world’s first human implantation of the Coherex WaveCrest LAA Occluder System * Salt Lake City cardiologist, Continue Reading →

.

Structural Heart Solutions

Copyright © 2017 Coherex Medical